BNIP3 pseudogene 44 (BNIP3P44)

BNIP3 pseudogene 44 (BNIP3P44) is listed in gene databases as a pseudogene related to the BNIP3 (BCL2 interacting protein 3) family, but there is no substantiated evidence for protein expression, known molecular function, or involvement in drug targeting. BNIP3P44 is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a known gene but generally nonfunctional due to mutations or truncations, and these loci are not typically expressed or biochemically active. There is no indication in major scientific sources or gene/protein databases that BNIP3P44 encodes an actual protein, has receptor, enzyme, transporter, or signaling activity, is implicated in disease, or interacts with any drugs. The canonical and functional BNIP3 gene is a member of the BCL2 family and is implicated in apoptosis, mitophagy, and cancer biology. In contrast, BNIP3P44 is one of several pseudogenes related to BNIP3, with no evidence of functional activity, protein production, or druggability. There is no mention of BNIP3P44 in literature regarding therapeutic targeting, mechanisms of action, drug interaction, or biomarkers. The presence of "pseudogene" in its name and the absence of protein-level characterization or functional annotation strongly supports its classification as non-target and information as likely either incorrect or irrelevant for therapeutic targeting. If the intent is to find functional details or roles in disease, the correct target would be the canonical BNIP3 protein, not BNIP3P44. Summary: BNIP3P44 is not a functional, druggable molecular target and is only a pseudogene. If seeking information on apoptosis, mitophagy, or cancer pathways relevant to BNIP3, refer to the canonical BNIP3 gene instead.

Other names

BNIP3P44BCL2 interacting protein 3 pseudogene 44BNIP3 pseudogene 44

null